the covid-19 vaccine developed by the university of oxford and astrazeneca will be more accessible to poor countries than vaccines from other companies. in particular, it is less demanding on storage conditions and will be much cheaper.
writes about this the guardian .
it is reported that astrazeneca vaccine can be transported and stored for up to six months under standard refrigeration conditions - at temperatures from +2 to +7. in addition, it will sell for around £ 3 ($ 4). this is several times cheaper than what pfizer / biontech and moderna offer.
the publication also writes that according to the test results, the effectiveness of the vaccine can still reach 90% at a lower concentration in the first dose. although the results at first glance look different from those of pfizer and moderna, scientists insist on the disparity, since oxford and astrazeneca vaccinated people in the mild to severe stage of covid-19.
another important clarification - the astrazeneca vaccine has shown high efficacy in both the elderly and young people.